X
19
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LIRAGLUTIDE RECOMBINANT, with a corresponding application number 206321.
Regulatory Information RX
With a dosage strength 18MG/3ML (6MG/ML)
Dosage Form Route SOLUTION; SUBCUTANEOUS
Reference Listed Drug Yes
Approved since 2014-12-23